BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-142@pharmaconomics
DTSTAMP:20260707T034601Z
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260428
SUMMARY:ACAD Approval — Nuplazid
DESCRIPTION:A final FDA approval decision on Nuplazid for its lead indication is expected Apr 27\, 2026.\n\nPrimary source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207318\n\nTrack it: https://www.pharmaconomics.com/e/142
URL:https://www.pharmaconomics.com/e/142
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ACAD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR